InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,709.54
(
0.01%
)
US TECH 100
19,316.00
(
0.34%
)
Dow Jones
42,196.52
(
0.09%
)
Brent Oil
74.62
(
0.26%
)
Bitcoin
60,779.65
(
-0.09%
)
Post# of 131
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

surf1944

Send PM Follow Ignore
Followers 466
Posts 26939
Boards Moderated 2
Alias Born 09/11/2006

surf1944

Re: surf1944 post# 12

Monday, 04/30/2012 9:17:15 AM

Monday, April 30, 2012 9:17:15 AM

Post# of 131
8:07AM Aegerion Pharma announces FDA acceptance of New Drug Application for review (AEGR) 12.44 : Co announces the FDA has accepted its New Drug Application for lomitapide, a once-daily, oral treatment for Homozygous Familial Hypercholesterolemia, for review. Co is seeking authorization to market lomitapide as an adjunct to a low-fat diet and other lipid-lowering therapies to reduce cholesterol in patients with HoFH. As previously disclosed, the FDA has classified the submission as a standard review with a 10-month Prescription Drug User Fee Act timetable.


surf's up......crikey



Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up